vaccine for immunising people 18 years or older. The authorisation recommends two full doses administered with an interval of between four and 12 weeks, the Anglo-Swedish firm said.The authorisation for the shots, developed under the codename AZD1222, paves the way for an emergency licensure by the Drug Controller General of India V.G.